» Articles » PMID: 37324799

Recent Applications of Immunomodulatory Biomaterials for Disease Immunotherapy

Overview
Date 2023 Jun 16
PMID 37324799
Authors
Affiliations
Soon will be listed here.
Abstract

Immunotherapy is used to regulate systemic hyperactivation or hypoactivation to treat various diseases. Biomaterial-based immunotherapy systems can improve therapeutic effects through targeted drug delivery, immunoengineering, etc. However, the immunomodulatory effects of biomaterials themselves cannot be neglected. In this review, we outline biomaterials with immunomodulatory functions discovered in recent years and their applications in disease treatment. These biomaterials can treat inflammation, tumors, or autoimmune diseases by regulating immune cell function, exerting enzyme-like activity, neutralizing cytokines, etc. The prospects and challenges of biomaterial-based modulation of immunotherapy are also discussed.

Citing Articles

Regulation of immune microenvironments by polyetheretherketone surface topography for improving osseointegration.

Zhao Y, An Y, Wu F, Liu L, Tay F, Jiao Y J Nanobiotechnology. 2025; 23(1):199.

PMID: 40069791 PMC: 11895393. DOI: 10.1186/s12951-025-03272-7.


Magnetically triggered thermoelectric heterojunctions with an efficient magnetic-thermo-electric energy cascade conversion for synergistic cancer therapy.

Yuan X, Kang Y, Li R, Niu G, Shi J, Yang Y Nat Commun. 2025; 16(1):2369.

PMID: 40064895 PMC: 11894112. DOI: 10.1038/s41467-025-57672-2.


Inflammation-triggered Gli1 stem cells engage with extracellular vesicles to prime aberrant neutrophils to exacerbate periodontal immunopathology.

Cai X, Zheng C, Guo H, Fan S, Huang X, Chen J Cell Mol Immunol. 2025; .

PMID: 40016585 DOI: 10.1038/s41423-025-01271-0.


Extracellular Vesicle-Based Strategies for Tumor Immunotherapy.

Jiramonai L, Liang X, Zhu M Pharmaceutics. 2025; 17(2).

PMID: 40006624 PMC: 11859549. DOI: 10.3390/pharmaceutics17020257.


YAP1 mediates the dimensional and chemical coordination of immunoregulation and therapy in extensively passaged mesenchymal stem cells.

Du F, Zhou F, Zhao N, Bao L, Hu C, Lei J Theranostics. 2025; 15(5):1930-1948.

PMID: 39897564 PMC: 11780522. DOI: 10.7150/thno.103314.


References
1.
Benezra M, Penate-Medina O, Zanzonico P, Schaer D, Ow H, Burns A . Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011; 121(7):2768-80. PMC: 3223837. DOI: 10.1172/JCI45600. View

2.
Pan H, Zheng M, Ma A, Liu L, Cai L . Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy. Adv Mater. 2021; 33(50):e2100241. DOI: 10.1002/adma.202100241. View

3.
Zhang R, Wang C, Guan Y, Wei X, Sha M, Yi M . Manganese salts function as potent adjuvants. Cell Mol Immunol. 2021; 18(5):1222-1234. PMC: 8093200. DOI: 10.1038/s41423-021-00669-w. View

4.
Wang C, Ye Y, Hu Q, Bellotti A, Gu Z . Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. Adv Mater. 2017; 29(29). DOI: 10.1002/adma.201606036. View

5.
Germic N, Frangez Z, Yousefi S, Simon H . Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation. Cell Death Differ. 2019; 26(4):715-727. PMC: 6460400. DOI: 10.1038/s41418-019-0297-6. View